MedTrace Logo

High Flow Nasal Canula Oxygen Helps Preoxygenate ARDS Patients

NCT02214576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-08-14

No results posted yet for this study

Summary

Tracheal intubation in the ICU is associated with significant complications and morbidity. Desaturation is among the most frequent and hazardous complication, occurring in almost one out of four intubations, that may in some instances lead to cardiac arrest; despite appropriate preoxygenation. Non-invasive ventilation may help improve preoxygenation but does not allow for apneic oxygenation and may not be performed in patients with neurological impairment. High flow nasal canula oxygen is increasingly used in the ICU in patients with acute hypoxemic respiratory failure and may be used to improve preoxygenation. It is currently used in our ICU for that purpose. Because high flow nasal canula oxygen is our first line oxyten therapy for patients with acute respirtory distress syndrome, we sought to determine its use as a means to ensure preoxygenation in those ARDS patients that require intubation.

Conditions

  • Acute Respiratory Distress Syndrome

Sponsors & Collaborators

  • Hôpital Louis Mourier

    lead OTHER

Principal Investigators

  • Jean-Damien RICARD, MD, PhD · University Paris Diderot and Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02214576 on ClinicalTrials.gov